(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Former hostage Eitan Mor on Hamas: ‘They will not give up until the last Israeli is gone' - 2Common ADHD medication prescribed in childhood may protect against risk of psychosis
- 3MacArthur Foundation awards $100M to outbreak surveillance network, a boost amid global health cuts
- 4New movies to watch this week: See 'Marty Supreme' in theaters, rent 'Springsteen: Deliver Me from Nowhere,' stream 'Cover-Up' on Netflix
- 5Italy's Beloved Trevi Fountain Hides A Unique Secret That Can Be Explored Underground
- Eight Muslim nations condemn Israel's 'dangerous' new death penalty law
- Struggling to keep your New Year's resolutions? Here's how to keep yourself on track
- Amy Poehler's podcast is a hit. It's also a Trojan horse for talking about women and aging.
- Heading to Florida for NASA's Artemis 2 moon launch? Here's what to know before you go
- Meet the rescue team behind the astronauts as Artemis II's launch approaches
- Photos: Hundreds Gather at Bondi Beach After Deadly Attack
- An Artemis 2 astronaut took a 'bath' on camera on the way to the moon. Mission Control's reaction was priceless (video)
- Vote In favor of Your #1 Electric Vehicles
- The Way to Fruitful Weight reduction: Individual Wellbeing Excursions
